FAPI Uptake in Avascular Necrosis of the Talus.
We present a case of metastatic castration-resistant prostate cancer (mCRPC) with prior hepatic involvement who ultimately received 177Lu-PSMA therapy.
APA
Saber Tanha A, Raeisi N, et al. (2026). FAPI Uptake in Avascular Necrosis of the Talus.. Clinical nuclear medicine. https://doi.org/10.1097/RLU.0000000000006197
MLA
Saber Tanha A, et al.. "FAPI Uptake in Avascular Necrosis of the Talus.." Clinical nuclear medicine, 2026.
PMID
41642049
Abstract
We present a case of metastatic castration-resistant prostate cancer (mCRPC) with prior hepatic involvement who ultimately received 177Lu-PSMA therapy. During the posttreatment scan following the third cycle, atypical uptake was observed in the left ankle, which was also evident as FAPI uptake on the 68Ga-FAPI-46 PET/CT performed for restaging, and was subsequently confirmed as avascular necrosis through MRI correlation. This case illustrates the false-positive uptake of 177Lu-PSMA-617 and 68Ga-FAPI-46 in avascular necrosis of the talus.
같은 제1저자의 인용 많은 논문 (5)
- Experience With 177Lu-FAPI-2286 Therapy as the Last Resort in a Patient With Metastatic Colon Cancer.
- Spondylodiscitis: A False-Positive Pitfall in 68 Ga-PSMA Scintigraphy.
- FAPI-Based Theranostics in Medullary Thyroid Cancer: A Viable Alternative When Somatostatin Receptor-Based Theranostics Show Limited Efficacy-A Clinical Experience.
- Superior Diagnostic Performance of ⁶⁸Ga-FAPI PET/CT Compared With ⁶⁸Ga-DOTATATE PET/CT in Medullary Thyroid Carcinoma.
- 99m Tc-PSMA Scintigraphy of Subcutaneous Angiolipoma.